Takeda Pharmaceutical Company Limited Increase Decrease In Contingent Consideration Asset Liability
Takeda Pharmaceutical Company Limited (TKPHF) reported Increase Decrease In Contingent Consideration Asset Liability of -JPY 602.00 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability · last filed 2025-06-25
| Period end | Increase Decrease In Contingent Consideration Asset Liability 12 month |
|---|---|
| 2025-03-31 | -602.00M JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 20.76B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 3.99B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | -11.20B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 59.28B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | -18.39B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -5.97B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 10.52B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | -18.44B JPY 20-F · filed 2019-06-27 |